DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

DUBLIN - Medtronic plc (NYSE:MDT), a global healthcare technology ... The system is currently compatible with the Guardian™ 4 sensor. Designed to ease the burden of carbohydrate counting and insulin ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...

Investors signalled that they were pleased with Medtronic plc's (NYSE:MDT) most recent earnings report. Looking deeper at the numbers, we found several encouraging factors beyond the headline ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...